DePrince Race & Zollo Inc (DRZ)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-313,378
Closed -$24.7M 192
2024
Q2
$24.7M Sell
313,378
-4,598
-1% -$377K 0.55% 90
2024
Q1
$27.7M Sell
317,976
-10,415
-3% -$889K 0.6% 85
2023
Q4
$27.1M Buy
328,391
+22,832
+7% +$1.74M 0.61% 76
2023
Q3
$23.9M Sell
305,559
-96,601
-24% -$8.09M 0.58% 84
2023
Q2
$35.4M Sell
402,160
-14,180
-3% -$1.22M 0.82% 35
2023
Q1
$33.6M Sell
416,340
-6,078
-1% -$495K 0.78% 45
2022
Q4
$32.8M Buy
422,418
+57,608
+16% +$4.67M 0.75% 46
2022
Q3
$29.5M Buy
364,810
+5,779
+2% +$519K 0.75% 53
2022
Q2
$32.2M Buy
359,031
+78,488
+28% +$7.95M 0.74% 58
2022
Q1
$31.1M Buy
+280,543
New +$29.6M 0.61% 77
2015
Q1
Sell
-541,929
Closed -$39.1M 290
2014
Q4
$39.1M Sell
541,929
-71,850
-12% -$4.99M 0.53% 89
2014
Q3
$38M Sell
613,779
-38,300
-6% -$2.44M 0.51% 89
2014
Q2
$41.6M Sell
652,079
-79,366
-11% -$4.82M 0.49% 87
2014
Q1
$45M Buy
731,445
+8,350
+1% +$486K 0.54% 77
2013
Q4
$41.5M Sell
723,095
-7,500
-1% -$425K 0.52% 79
2013
Q3
$38.9M Sell
730,595
-133,692
-15% -$7.19M 0.53% 74
2013
Q2
$44.5M Buy
+864,287
New +$42.7M 0.61% 59

Other funds holding MDT

DePrince Race & Zollo Inc (DRZ)'s MDT Position: Q3 2024 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Medtronic (MDT) in Q3 2024, closing a stake of 313,378 shares — an estimated $24.7M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in MDT in Q2 2013 and held it in 17 quarters. The position peaked at $45M in Q1 2014. 2,065 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 313,378 Medtronic shares in Q3 2024, an estimated $24.7M.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in Medtronic in Q2 2013 and held it in 17 quarters.
  • DePrince Race & Zollo Inc (DRZ)'s Medtronic position peaked at $45M in Q1 2014.
  • 2,065 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q3 2024, filed 14 Nov 2024.